Earnings · China A-shares
Realcan Pharmaceutical Group Co., Ltd. Class A (002589) earnings
Realcan Pharmaceutical Group Co., Ltd. Class A published its Q3 report on 2026-10-26: net profit -23.68% year on year, -355.65% excluding one-off items. Wave Radar's earnings-quality score is 82 of 100 (Sound). The stock moved -5.50% in the 3 trading days after the report.
- Report
- Q3 report
- Published
- 2026-10-26
- Period end
- 2026-09-30
- Net profit YoY
- -23.68%
- Excl. one-offs YoY
- -355.65%
- Net profit QoQ
- -345.40%
- Result
- Bad / loss
- Quality score
- 82
- Quality
- Sound
Stock move after the report
Trading days from the first tradeable session; dividend-adjusted. "vs index" is the excess return over CSI 300 for A-shares.
| After | Return | vs index |
|---|---|---|
| 1 day | -4.12% | — |
| 3 days | -5.50% | — |
| 7 days | -2.41% | — |
| 14 days | -5.15% | — |
Report history
Over the last 8 reports, net profit grew year on year in 2 of them. The stock rose in the 3 trading days after 3 of 8 reports (average -1.10%).
| Report | Published | Net profit | Profit YoY | Excl. one-offs YoY | Revenue YoY | EPS | ROE | 3 days after | 30 days after | 30d vs index |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026 Q3 report | 2026-10-27 | ¥9.26M | -23.68% | — | -4.90% | 0.01 | 0.17% | -5.50% | — | — |
| 2026 interim report | 2026-08-21 | ¥11.14M | -38.70% | +86.73% | -3.63% | 0.01 | 0.21% | -4.14% | -0.89% | +4.82% |
| 2026 Q1 report | 2026-04-25 | ¥10.37M | -14.20% | -7.78% | -2.80% | 0.01 | 0.20% | +0.93% | -16.46% | -16.16% |
| 2025 annual report | 2026-04-23 | ¥16.07M | +30.73% | +53.12% | -8.42% | 0.01 | 0.29% | -3.60% | -17.72% | -16.16% |
| 2025 Q3 report | 2025-10-30 | ¥12.14M | -63.05% | +184.63% | -10.73% | 0.01 | 0.22% | +1.03% | +34.48% | +39.23% |
| 2025 interim report | 2025-08-26 | ¥18.17M | -32.35% | +42.54% | -12.11% | 0.01 | 0.33% | -3.58% | -6.84% | -8.52% |
| 2025 Q1 report | 2025-04-30 | ¥12.09M | -6.58% | -45.39% | -12.98% | 0.01 | 0.22% | +7.42% | +4.24% | +1.06% |
| 2024 annual report | 2025-04-24 | ¥12.29M | +1.50% | +37.30% | -0.84% | 0.01 | 0.22% | -1.40% | +7.02% | +4.75% |
The last 8 reports. Net profit is attributable to shareholders and year-to-date (a Q3 report covers the first nine months). Moves count trading days from the first tradeable session after publication; "30d vs index" is the excess return over CSI 300.
How to read this
Results are grouped by reported profit growth (great, good, neutral, bad or a loss). For China A-shares the quality score starts at 100 and loses points for gaps a reader can check: operating cash falling short of profit, receivables or inventory outrunning revenue, profit that rests on one-off items or subsidies, heavy goodwill and a qualified audit opinion.
Figures are generated automatically from Wave Radar's published market data and refresh after each market close.